Organigram Global (OGI) Gains from Equity Investments (2018 - 2026)

Organigram Global (OGI) has reported Gains from Equity Investments for 7 consecutive years, with $28.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Gains from Equity Investments rose 103.65% year-over-year to $28.1 million; the TTM figure through Mar 2026 stood at $91.1 million (up 559.02% YoY), while the FY2025 annual figure was $67.2 million, changed N/A from the prior year.
• Gains from Equity Investments slipped to $28.1 million in Q1 2026 per OGI's latest filing, from $39.2 million in the prior quarter.
• Across five years, Gains from Equity Investments topped out at $39.2 million in Q4 2025 and bottomed at $10.1 million in Q4 2024.
• Historically, Gains from Equity Investments has averaged $22.8 million across 3 years, with a median of $20.9 million in 2025.
• Annual changes were most pronounced in 2025 — Gains from Equity Investments soared 287.49% — and 2026, when it jumped 103.65%.
• Organigram Global's Gains from Equity Investments stood at $10.1 million in 2024, then jumped by 287.49% to $39.2 million in 2025, then decreased by 28.27% to $28.1 million in 2026.
• Business Quant data shows OGI's Gains from Equity Investments at $28.1 million in Q1 2026, $39.2 million in Q4 2025, and $13.8 million in Q1 2025.